secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001104659-23-030141
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics secures $11M loan from Streeterville Capital
----------------------------------------------------------------------

- Loan of $11,005,000 from Streeterville Capital, maturity 22 months, repayments start Nov 2023.
- Interest at 8% per annum, with 10% original issue discount; prepayment allowed with 10% charge.
- Proceeds for Sawston facility buildout, product approval preparation, and general operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923030141/0001104659-23-030141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465923030141/tm238973_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-030141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer